Lixte Biotechnology : 10-Q Filing Q1 2023 : vimarsana.com

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 10-Q


... | May 10, 2023

Related Keywords

United States , Netherlands , Washington , California , Amsterdam , Noord Holland , Valencia , Carabobo , Venezuela , Delaware , China , Broto , Comunidad Autonoma De Aragon , Spain , Tennessee , Tampa , Florida , Barcelona , Comunidad Autonoma De Cataluna , Madrid , Spanish , Javier Mart , Julie Forman , Johns Kovach , Regina Brown , Robertn Weingarten , Stephen Forman , Philip Palmedo , Ericj Forman , Medicamentosy Productos Sanitarios , Gil Schwartzberg , Morgan Stanley , Company Annual Meeting Of Stockholders , Nasdaq , Company Vice , Drug Administration , Company Overview , Company Annual Report On Form , Party Transactions , Morgan Stanley Smith Barney , Securities Investor Protection Corporation , Nasdaqstock Market , Deposit Insurance Corporation , Securities Exchange , National Institute Of Neurologic Disorders , Spanish Sarcoma Group Grupo Espa , Research Institute Hospital Inc , Spanish Sarcoma Group , Exchange Commission , Board Of Directors The Company , Scientific Advisory Committee , City Of Hope National Medical Center , Exchange Commission On , National Cancer Institute Pharmacologic Clinical Trial , National Cancer Institute , Nasdaq Stock Market , Theradex Systems Inc , Development Collaboration Agreement , Clinical Trial Research Agreement , National Institutes Of Health , Spanish Sarcoma Research Group Grupo Espa , Company Scientific Advisory Committee , Company Board Of Directors , European Union , Netherlands Cancer Institute , Consulting Corp , Exchange Act , Lixte Biotechnology Inc , Spanish Agency For Medicines , Pfizer , City Of Hope Medical Foundation , Clinical Research Support Agreement , University Hospital Madrid , Moffitt Cancer Center , University Hospital , Loncode Institute , Lixte Biotechnology Holdings Inc , Company Business Activities , Sarah Cannon Research Institute , Company Certificate Of Incorporation , Health Products Agencia Espa , Development Agreement , Colorado Boulevard , Zip Code , Purchase Common Stock , Securities Exchange Act , Interactive Data File , Regulations T , Convertible Preferred Stock , Months Ended March , Lixte Biotechnology Holdings , Lixte Biotechnology , Annual Report , Continued Listing , Nasdaq Capital Market , Nasdaq Listing Rule , Listing Rule , Nasdaq Capital , Significant Accounting , Chief Operating Decision Maker , Chief Executive Officer , Chief Scientific , Morgan Stanley Wealth Management , Federal Deposit Insurance Corporation , Stanley Wealth Management , Licensing Legal , Filing Fees , Financial Accounting Standards Board , Accounting Standards Update , Earnings Per Share , Own Equity , Certain Modifications , Delaware Secretary , Chief Scientific Officer , Chief Medical Officer , Chief Administrative Officer , Vice President , Chief Operating Officer , Chief Financial Officer , Incentive Plan , Annual Meeting , Average Remaining Contractual Life , Effective August , Investigational New Drug Application , Collaboration Agreement , Investigator Initiated Clinical Trial , Grupo Espa , Spanish Agency , Health Products , Agencia Espa , Productos Sanitarios , United States Dollar , Effective January , Hope National Medical Center , Hope Medical Foundation , Cancer Institute Pharmacologic Clinical , Cooperative Research , Theradex Systems , Exclusive License Agreement , License Agreement , Licensed Patents , Effective Date , Nvalid Claims , Significant Agreements , Scientific Advisory , Effective September , Risks Associated , Quarterly Report , Securities Act , Spanish Sarcoma Research Group , Coordinating Investigator , Accounting Policies , Business Activities , National Institute , Neurologic Disorders , National Institutes , Capital Resources , Exchange Act Rules , Disclosure Controls , Internal Control Over Financial , Risk Factors , Principal Executive Officer , Principal Financial , Accounting Officer , Nc Stock Exchange , News , Information , Press Release , United , Securities , End , Exchange , Orm Lixt Us5393192027 ,